|
|
||||||||
Articles |
Factors regulating the differentiation of sheep subcutaneous and abdominal (omental or perirenal) preadipocytes from foetal lambs, suckling lambs and fattening sheep have been investigated using a serum-free cell culture system. Differentiation was assessed by changes in the activity of the enzyme glycerol 3-phosphate dehydrogenase. Insulin or IGF-I was essential for differentiation. Dexamethasone, a lipid supplement (Excyte) and the thiazolidinedione, rosiglitazone (BRL 49653) (a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist) all enhanced preadipocyte differentiation, whereas fibroblast growth factor and GH were inhibitory. The most effective combination was insulin, triiodothyronine, dexamethasone and rosiglitazone. Under suboptimal conditions, preadipocytes from fattening sheep differentiated less well than cells from suckling and foetal lambs. Also, under suboptimal conditions, abdominal preadipocytes did not differentiate as well as subcutaneous preadipocytes. However, age and depot differences were minimised when cells were cultured with insulin, triiodothyronine, rosiglitazone and either dexamethasone or lipid. The results suggest that variation in the ability to produce the natural ligand for PPAR-gamma contributes to depot- and age-specific differences in the ability of preadipocytes to differentiate.
This article has been cited by other articles:
![]() |
A. C. Grant, G. Ortiz-Colon, M. E. Doumit, R. J. Tempelman, and D. D. Buskirk Differentiation of bovine intramuscular and subcutaneous stromal-vascular cells exposed to dexamethasone and troglitazone J Anim Sci, October 1, 2008; 86(10): 2531 - 2538. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Duffield, T. Vuocolo, R. Tellam, B. S. Yuen, B. S. Muhlhausler, and I. C. McMillen Placental restriction of fetal growth decreases IGF1 and leptin mRNA expression in the perirenal adipose tissue of late gestation fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1413 - R1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Grant, G. Ortiz-Colon, M. E. Doumit, and D. D. Buskirk Optimization of in vitro conditions for bovine subcutaneous and intramuscular preadipocyte differentiation J Anim Sci, January 1, 2008; 86(1): 73 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Tomlinson, N. Crabtree, P. M. S. Clark, G. Holder, A. A. Toogood, C. H. L. Shackleton, and P. M. Stewart Low-Dose Growth Hormone Inhibits 11{beta}-Hydroxysteroid Dehydrogenase Type 1 but Has No Effect upon Fat Mass in Patients with Simple Obesity J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2113 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Choi, S.-G. Roh, Y.-H. Hong, Y. B. Shrestha, D. Hishikawa, C. Chen, M. Kojima, K. Kangawa, and S.-I. Sasaki The Role of Ghrelin and Growth Hormone Secretagogues Receptor on Rat Adipogenesis Endocrinology, March 1, 2003; 144(3): 754 - 759. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |